Literature DB >> 495693

Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

G W Hunninghake, J E Gadek, O Kawanami, V J Ferrans, R G Crystal.   

Abstract

Bronchoalveolar lavage is an invaluable means of accurately evaluating the inflammatory and immune processes of the human lung. Although lavage recovers only those cells and proteins present on the epithelial surface of the lower respiratory tract, comparison with open lung biopsies shows that these constituents are representative of the inflammatory and immune systems of the alveolar structures. With the use of these techniques, sufficient materials are obtained from normal individuals to allow characterization of not only the types of cells and proteins present but their functions as well. Such observations have been useful in defining the inflammatory and immune capabilities of the normal lung and provide a basis for the study of lung disease. Lavage methods have been used to characterize inflammatory and immune processes of the lower respiratory tract in destructive, infectious, neoplastic, and interstitial disorders. From the data already acquired, it is apparent that bronchoalveolar lavage will yield major insights into the pathogenesis, staging, and therapy decisions involved in these disorders. (Am J Pathol 97:149--206, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495693      PMCID: PMC2042387     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  135 in total

1.  Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants.

Authors:  H Carp; A Janoff
Journal:  Am Rev Respir Dis       Date:  1978-09

2.  IMMUNOGLOBULINS IN NORMAL HUMAN TRACHEOBRONCHIAL WASHINGS: A QUALITATIVE AND QUANTITATIVE STUDY.

Authors:  R I KEIMOWITZ
Journal:  J Lab Clin Med       Date:  1964-01

3.  Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers.

Authors:  R J Rodriguez; R R White; R M Senior; E A Levine
Journal:  Science       Date:  1977-10-21       Impact factor: 47.728

Review 4.  Animal models of emphysema.

Authors:  J B Karlinsky; G L Snider
Journal:  Am Rev Respir Dis       Date:  1978-06

5.  Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids.

Authors:  H Tegner
Journal:  Acta Otolaryngol       Date:  1978 Mar-Apr       Impact factor: 1.494

6.  Histochemical staining and in vitro spreading of human pulmonary alveolar macrophages: variability with cigarette smoking status.

Authors:  G A Warr; R R Martin
Journal:  J Reticuloendothel Soc       Date:  1978-01

7.  The role of elastases in the development of emphysema.

Authors:  C Kuhn; R M Senior
Journal:  Lung       Date:  1978       Impact factor: 2.584

8.  Particulate concentrations in pulmonary alveolar proteinosis.

Authors:  D D McEuen; J L Abraham
Journal:  Environ Res       Date:  1978-12       Impact factor: 6.498

9.  Human alveolar macrophage proteolytic enzyme activities in chronic obstructive pulmonary disease. Lack of correlation with functional abnormalities.

Authors:  W L Coudon; J O Harris
Journal:  Chest       Date:  1978-03       Impact factor: 9.410

10.  Elastase secretion by peritoneal exudative and alveolar macrophages.

Authors:  R White; H S Lin; C Kuhn
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  205 in total

1.  Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs.

Authors:  A Ben-Jebria; D Chen; M L Eskew; R Vanbever; R Langer; D A Edwards
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 2.  The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema.

Authors:  J E Gadek; E R Pacht
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

4.  Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage.

Authors:  Ellen L Burnham; Jeanette Gaydos; Edward Hess; Robert House; Jacinta Cooper
Journal:  Alcohol Alcohol       Date:  2010-08-20       Impact factor: 2.826

5.  Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

Authors:  R C Hubbard; F Ogushi; G A Fells; A M Cantin; S Jallat; M Courtney; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

6.  Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

Authors:  Lien Van Hoecke; Emma Richelle Job; Xavier Saelens; Kenny Roose
Journal:  J Vis Exp       Date:  2017-05-04       Impact factor: 1.355

7.  Limiting-dilution analysis of T cells extracted from solid human lung tissue: comparison of precursor frequencies for proliferative responses and lymphokine production between lung and blood T cells from individual donors.

Authors:  P G Holt; U R Kees; M A Shon-Hegrad; A Rose; J Ford; N Bilyk; R Bowman; B W Robinson
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

8.  Semi-quantitative gallium-67 lung scanning as a measure of the intensity of alveolitis in pulmonary sarcoidosis.

Authors:  G J Duffy; K Thirumurthi; M Casey; F Barker; N Brennan; C Odlum; M X Fitzgerald
Journal:  Eur J Nucl Med       Date:  1986

9.  Severe spirometric defects in systemic lupus erythematosus. A possible role for bronchoalveolar lavage and gallium scanning.

Authors:  R Y Lin
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

10.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; J E Gadek; T J Lawley; R G Crystal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.